| Application number | Title of the application | Filing Date | Status |
|---|
| 07/984039 | METHOD AND COMPOSITIONS FOR TREATING SLEEP DISORDERS, CONVULSIVE SEIZURES, AND OTHER DISORDERS USING OPTICALLY PURE (+) ZOPICLONE | Nov 30, 1992 | Abandoned |
| 07/984032 | METHODS AND COMPOSITIONS FOR TREATING HYPERTENSION, ANGINA AND OTHER DISORDERS USING OPTICALLY PURE S(-) FELODIPINE | Nov 30, 1992 | Abandoned |
Array
(
[id] => 3028817
[patent_doc_number] => 05317031
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-31
[patent_title] => 'Cholesterol lowering compounds'
[patent_app_type] => 1
[patent_app_number] => 7/982163
[patent_app_country] => US
[patent_app_date] => 1992-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7217
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/317/05317031.pdf
[firstpage_image] =>[orig_patent_app_number] => 982163
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/982163 | Cholesterol lowering compounds | Nov 23, 1992 | Issued |
| 07/978057 | ADDITIVES TO FEMININE PRODUCTS | Nov 17, 1992 | Abandoned |
Array
(
[id] => 2995660
[patent_doc_number] => 05362757
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-11-08
[patent_title] => 'Composition and method containing optically pure (S) metoprolol'
[patent_app_type] => 1
[patent_app_number] => 7/976676
[patent_app_country] => US
[patent_app_date] => 1992-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2080
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/362/05362757.pdf
[firstpage_image] =>[orig_patent_app_number] => 976676
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/976676 | Composition and method containing optically pure (S) metoprolol | Nov 15, 1992 | Issued |
Array
(
[id] => 3510468
[patent_doc_number] => 05563140
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-10-08
[patent_title] => 'Use of 1-(aminoalkyl)-3-(benzyl)-quinoxaline-2-one derivatives for the preparation of neuroprotective compositions'
[patent_app_type] => 1
[patent_app_number] => 7/975328
[patent_app_country] => US
[patent_app_date] => 1992-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 3010
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/563/05563140.pdf
[firstpage_image] =>[orig_patent_app_number] => 975328
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/975328 | Use of 1-(aminoalkyl)-3-(benzyl)-quinoxaline-2-one derivatives for the preparation of neuroprotective compositions | Nov 15, 1992 | Issued |
Array
(
[id] => 3014159
[patent_doc_number] => 05308837
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-05-03
[patent_title] => '5\'-amine substituted adenosine analogs as immunosuppressants'
[patent_app_type] => 1
[patent_app_number] => 7/975211
[patent_app_country] => US
[patent_app_date] => 1992-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11500
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/308/05308837.pdf
[firstpage_image] =>[orig_patent_app_number] => 975211
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/975211 | 5'-amine substituted adenosine analogs as immunosuppressants | Nov 11, 1992 | Issued |
Array
(
[id] => 3462351
[patent_doc_number] => 05468763
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-21
[patent_title] => 'Use of a glycine B partial agonist for memory and learning enhancement or treatment of a cognitive disorder'
[patent_app_type] => 1
[patent_app_number] => 7/975298
[patent_app_country] => US
[patent_app_date] => 1992-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4255
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/468/05468763.pdf
[firstpage_image] =>[orig_patent_app_number] => 975298
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/975298 | Use of a glycine B partial agonist for memory and learning enhancement or treatment of a cognitive disorder | Nov 11, 1992 | Issued |
Array
(
[id] => 2990636
[patent_doc_number] => 05346921
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-09-13
[patent_title] => 'Treatment of inflammation with 15-keto-prostaglandin compounds'
[patent_app_type] => 1
[patent_app_number] => 7/972092
[patent_app_country] => US
[patent_app_date] => 1992-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19399
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 306
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/346/05346921.pdf
[firstpage_image] =>[orig_patent_app_number] => 972092
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/972092 | Treatment of inflammation with 15-keto-prostaglandin compounds | Nov 4, 1992 | Issued |
Array
(
[id] => 3072284
[patent_doc_number] => 05364847
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-11-15
[patent_title] => 'Inhibitors of sex steroid biosynthesis and methods for their production and use'
[patent_app_type] => 1
[patent_app_number] => 7/966112
[patent_app_country] => US
[patent_app_date] => 1992-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13093
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 1390
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/364/05364847.pdf
[firstpage_image] =>[orig_patent_app_number] => 966112
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/966112 | Inhibitors of sex steroid biosynthesis and methods for their production and use | Oct 21, 1992 | Issued |
Array
(
[id] => 3029882
[patent_doc_number] => 05342834
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-08-30
[patent_title] => 'Method for androgen supplementation'
[patent_app_type] => 1
[patent_app_number] => 7/962043
[patent_app_country] => US
[patent_app_date] => 1992-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3661
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/342/05342834.pdf
[firstpage_image] =>[orig_patent_app_number] => 962043
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/962043 | Method for androgen supplementation | Oct 14, 1992 | Issued |
| 07/950827 | INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH BUFFERED METRONIDAZOLE COMPOSITIONS | Sep 23, 1992 | Abandoned |
| 07/945374 | COMPOSITIONS COMPRISING CARBONATE/BICARBONATE BUFFERED DICHLOROACETIC ACID AND METHODS FOR TREATMENT OF METABOLIC AND CARDIOVASCULAR DISORDERS | Sep 15, 1992 | Abandoned |
Array
(
[id] => 3006016
[patent_doc_number] => 05374657
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-12-20
[patent_title] => 'Microbial oil mixtures and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 7/944739
[patent_app_country] => US
[patent_app_date] => 1992-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9028
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/374/05374657.pdf
[firstpage_image] =>[orig_patent_app_number] => 944739
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/944739 | Microbial oil mixtures and uses thereof | Sep 13, 1992 | Issued |
| 07/938800 | NOVEL COMPOSITIONS OF ANGIOTENSIN-II RECEPTOR ANTAGONISTS AND CALCIUM CHANNEL BLOCKERS | Aug 31, 1992 | Abandoned |
| 07/936709 | TREATMENT OF ANXIETY DISORDERS | Aug 26, 1992 | Abandoned |
| 07/934038 | MEDICAMENT FOR THE TOPICAL TREATMENT OF SKIN | Aug 23, 1992 | Issued |
| 07/929737 | FEED ADDITIVE CONTAINING ZINC BACITRACIN | Aug 12, 1992 | Abandoned |
Array
(
[id] => 3438547
[patent_doc_number] => 05377618
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-01-03
[patent_title] => 'Method for preferential production of ratites of a desired sex'
[patent_app_type] => 1
[patent_app_number] => 7/922831
[patent_app_country] => US
[patent_app_date] => 1992-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 1983
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/377/05377618.pdf
[firstpage_image] =>[orig_patent_app_number] => 922831
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/922831 | Method for preferential production of ratites of a desired sex | Jul 30, 1992 | Issued |
| 07/903525 | ESTRENE STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN HYPOTHALAMIC FUNCTION AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS | Jun 23, 1992 | Abandoned |